A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 11, entitled, “Mitophagy and cancer: role of BNIP3/BNIP3L as energetic drivers of stemness features, ATP production, proliferation, and cell migration.”
ESC 2024: Latest FLOW trial analysis highlights how Ozempic can benefit CKD patients – Pharmaceutical Technology
Two nurses preparing a patient for hemodialysis. The latest Flow trial data indicates Novo Nordisk’s Ozempic (semaglutide) can benefit patients with chronic kidney disease. Image